World Halitosis Treatment Market Is Expected To Reach USD 22,153.4 Billion By 2023

According to American Dental Association (ADA), halitosis is a “chronic bad breath”, an unpleasant smell in the breath which is detectable by other people. Bad breadth is a major problem across the globe affecting social life of the people. It may lead to stress and psychological pressure further resulting into negative impact on person’s life. Wide range of oral care products are available for the treatment of halitosis. Major market players are engaged in the manufacturing of oral care products in different flavours to attract more and more customers while maintaining the product quality.

According to a recent study report published by the Market Research Future analysts, the global halitosis treatment market is growing at a rapid pace with a double digit growth rate. This growth is mainly due to the increasing prevalence of halitosis and periodontal diseases. According to Journal of Natural Science, Biology and Medicine, Halitosis is very common among the general population and nearly more than 50% of the general population have halitosis. Moreover, technological advancement in the field of dentistry, for instance use of breathalysers to detect the levels of bacteria’s which causes bad breath has spurred the growth of global halitosis market.

Get a sample report at https://www.marketresearchfuture.com/sample_request/3758 .

There are numerous players operates in this market all over the globe. Many organizations especially in North American, European and Asian region have their own manufacturing units. While some organizations outsource their facility of manufacturing to other organizations. There are plenty of large and small market players available in the market which provide the treatment products for halitosis. Listerine was the first company who coined the term “halitosis” and became the largest brand with mouthwash which kills the bad breath. Listerine created a market for its mouthwash, until that time, bad breath was not conventionally considered a catastrophe.

Many players are now getting into research and development for various clinical studies to provide effective products to the patient suffering from halitosis and will help to decrease the recurrence of the disease globally. For instance, players like Rowpar Pharmaceuticals, Inc. has just completed a panel of clinical studies in support of the Seal of Acceptance for the treatment of oral malodor (halitosis). The ADA Council on Science Affairs in May accepted the rinses after finding the products effective and safe for use when used as directed.

Colgate-Palmolive Company (U.S), All USA Partners LLC (U.S), Dr. Harold Katz, LLC (U.S), Rowpar Pharmaceuticals, Inc. (U.S), Abbott (U.S), Listerine (U.S), and AstraZeneca (U.S) are some of the prominent players at the forefront of competition in the global halitosis treatment market and are profiled in MRFR Analysis.

Browse complete report at https://www.marketresearchfuture.com/reports/halitosis-treatment-market-3758 .

The American market for halitosis holds the largest in the global market. North America is the largest market whose growth is attributed to increase in population suffering from halitosis and gums diseases. In 2013, in the US, USD 810 million was spent for halitosis treatment. According Centers for Disease Control and Prevention, increasing prevalence of periodontal disease is found in the U.S. population. It also stated that 47.2% of the total population has periodontal disease.

Europe holds the second position in the market. Rising awareness about consequence of bad breath and its impact on the social life has persuaded people to take treatment. According to WHO, in Germany, 20% of the people were suffering from halitosis in 2015. Availability of affordable treatment options and demand of new products drive the European market.

Asia Pacific is expected to be the largest market for halitosis treatment in the near future. Lack of awareness among the people about their oral health and changing lifestyle contribute to the growth of this market. According to WHO, 24% of the Japanese population have oral odour. Also, increasing level of stress due to bad breath has been found in the Japanese population. In 2016, 24% of Chinese population suffered from halitosis. In India, nearly 50 million suffered from halitophobia (fear of bad breath) in 2012, while only 255 of this population actually had the problem.

The Middle East and Africa show steady growth in the halitosis treatment market. Lack of oral hygiene, and demand oral health products such as toothpastes and mouthwashes drive the market in this region.

About us
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@Marketresearchfuture.Com
Web: Https://Www.Marketresearchfuture.Com

This release was published on openPR.